Medical instrument system and related method, and device and medium
By combining the first and second analyte devices, establishing calibration relationships, and performing individualized calibrations, the shortcomings of non-invasive analyte monitoring methods in terms of accuracy and stability are addressed, enabling the acquisition of high-accuracy analyte level information on low-burden and low-cost devices.
Patent Information
- Application Number
- PCT/CN2026/095786
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-08
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Existing non-invasive analyte monitoring methods have shortcomings in terms of accuracy and long-term stability, especially due to the influence of factors such as skin, fat, protein, moisture, temperature, contact pressure and individual differences, which lead to insufficient accuracy and long-term stability of optical signals.
By combining the first analyte device and the second analyte device, a calibration relationship is established by acquiring continuous measurement data and analyte data within a first time period. Individualized calibration is then performed using a processing device. In subsequent time periods, when using the first analyte device, the measurement data is processed based on the calibration relationship to improve the accuracy of analyte level information.
While maintaining the advantages of non-invasive or low-intrusive devices in terms of low burden and low cost, it significantly improves the accuracy and stability of analyte-level information, reduces noise interference, and enhances the accuracy and generalization ability of identifying target relationships.
Smart Images

Figure CN2026095786_12112026_PF_FP_ABST
Abstract
Description
Medical device systems and related methods, equipment and media Technical Field
[0001] This disclosure generally relates to the field of medical devices, and specifically to a medical device system and related methods, equipment and media. Background Technology
[0002] Diabetes is a chronic metabolic disease characterized by insufficient insulin or impaired insulin action, leading to elevated analyte levels. Monitoring blood glucose levels can help diabetic patients develop self-management habits and reduce the likelihood of various neurological disorders, cardiovascular and cerebrovascular diseases, microvascular diseases, and complications caused by large fluctuations in blood glucose.
[0003] Current analyte monitoring generally includes invasive and non-invasive methods. Invasive analyte monitoring can include traditional finger-prick blood sampling and continuous analyte monitoring. Continuous analyte monitoring involves placing at least a portion of a sensor under the skin of the target subject (e.g., a diabetic patient) and bringing it into contact with the subcutaneous fluid, thereby continuously obtaining relatively accurate analyte levels. Non-invasive analyte monitoring typically does not require contact with the target subject's subcutaneous fluid and can obtain analyte levels using methods such as optical, microwave, radio frequency, or ultrasound.
[0004] However, while non-invasive analyte monitoring offers advantages such as painlessness and low long-term cost, the accuracy of the corresponding analyte level information still needs improvement. For example, in a typical non-invasive blood glucose monitoring scheme based on an optical probe, near-infrared radiation can be coupled into the skin via a transmitting fiber or transmitting channel, and the radiation returning from the tissue is received by a receiving fiber or receiving channel isolated from the transmitting channel. A spectrometer then analyzes the light intensity or absorption spectrum at different wavelengths. To improve the signal-to-noise ratio of weak glucose-related spectral information, this type of scheme typically requires controlling the geometric relationship between the transmitting and receiving channels, reducing direct surface reflection, and mechanically or thermally isolating the receiving optical path. Although this type of scheme provides a non-invasive detection pathway, factors such as skin, fat, protein, moisture, temperature, contact pressure, and individual differences can all affect the optical signal. Therefore, relying solely on the non-invasive optical signal may still result in insufficient accuracy and long-term stability. Summary of the Invention
[0005] This disclosure is made in view of the above-mentioned situation, and its purpose is to provide a medical device system, related methods, devices, and media that can combine the advantages of multiple analyte devices, thereby improving the accuracy of analyte level information corresponding to analyte data. In particular, if continuous and relatively accurate glucose data obtained by a continuous glucose monitoring device over a period of time can be used to individually calibrate the continuous optical signal or initial glucose estimate obtained by a non-invasive optical device, and this individualized calibration relationship can be reused in subsequent non-invasive use, it helps to simultaneously take into account the accuracy of continuous reference data and the advantages of non-invasive devices such as low burden, low cost, or long-term wear.
[0006] To this end, the first aspect of this disclosure provides a medical device system, including a first analyte device, a second analyte device, and a processing device. The first analyte device is configured to acquire continuous first measurement data of a target object within a first time period in a non-invasive or low-invasive manner, and to acquire continuous third measurement data of the target object within a second time period after the first time period. The first measurement data and the third measurement data include at least one of an original detection signal, feature data obtained from the original detection signal, and initial analyte data. The second analyte device is a continuous analyte monitoring device and is configured to acquire continuous second analyte data of the target object within the first time period. The processing device is configured to determine a calibration relationship based on the correspondence between the first measurement data and the second analyte data at multiple times within the first time period, and to process the third measurement data based on the calibration relationship to obtain calibrated analyte level information. In this case, the continuous analyte data of the second analyte device can serve as individualized continuous reference data for the first analyte device, thereby improving the accuracy of subsequent analyte level information acquisition while retaining the low-burden advantage of non-invasive or low-invasive devices.
[0007] In addition, in the medical device system according to the first aspect of this disclosure, optionally, the processing device is configured to establish a mapping model using the target information in the first measurement data and the target information in the second analyte data as training samples or fitting samples, and determine at least one of the target analyte level, analyte change trend, low analyte state, high analyte state and analyte fluctuation information corresponding to the third measurement data based on the mapping model.
[0008] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the processing device is further configured to perform at least one of the following processing on the first measurement data and the second analyte data before determining the calibration relationship: timestamp alignment, sampling frequency matching, filtering, outlier removal, time delay estimation, and trend segment matching, so that continuous data from the second analyte device serves as individualized continuous reference data for the first analyte device.
[0009] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the first analytical device includes an optical analytical device, and the original detection signal includes at least one of photoplethysmography signal, reflectance spectrum signal, transmission spectrum signal, diffuse reflectance spectrum signal, light intensity signal, absorption spectrum signal, and scattering signal.
[0010] In addition, in the medical device system disclosed in the first aspect, the feature data may optionally include at least one of light intensity ratio of different wavelengths or different channels, AC component, DC component, pulse waveform features, absorption peak features, spectral filtering features, temperature compensation features, and contact state features.
[0011] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the processing device is configured to determine multiple sub-calibration relationships based on target features within the first time period, and in response to identifying features that are the same as or match the target features within the second time period, invoke the corresponding sub-calibration relationships to process the third measurement data.
[0012] Additionally, in the medical device system disclosed in the first aspect, the target features may optionally include at least one of diet, exercise, medication, sleep, physical condition, data waveform morphology, rate of change, temperature, humidity, contact state, and wearing position.
[0013] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the processing device is configured to constrain the calibration relationship based on trend information of the second analyte data, the trend information including at least one of upward trend, downward trend, stationary trend, rate of change, acceleration of change, postprandial peak, nighttime low, and time within a target range.
[0014] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the processing device is further configured to perform weighted updates or pause updates of the calibration relationship based on quality indicators of the first measurement data and / or the second analyte data.
[0015] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the second analyte device includes an on-body unit, the on-body unit including an electrochemical sensor at least partially disposed under the skin of the target object and in contact with tissue fluid, and an electronic device operatively connected to the electrochemical sensor; the electrochemical sensor is configured to generate an electrical signal based on the target analyte in the tissue fluid, and the electronic device is configured to process the electrical signal and output the continuous second analyte data via a wired or wireless means.
[0016] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, it further includes an application portion configured to adhere the body unit to the body surface of the target object.
[0017] Additionally, in the medical device system disclosed in the first aspect, optionally, the second analyte device includes a continuous glucose monitoring device, wherein the analyte is glucose; the first analyte device is a non-invasive glucose monitoring device, and is configured to obtain glucose level information within the second time period using the calibration relationship determined by the continuous glucose data of the continuous glucose monitoring device when the second analyte device is removed, deactivated, or not worn.
[0018] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the processing device is disposed in at least one of the first analyte device, the second analyte device, a mobile terminal, a reading device, and a server; when the processing device is disposed in the mobile terminal, the reading device, or the server, the processing device is configured to receive the first measurement data and / or the third measurement data from the first analyte device, and to receive the second analyte data from the second analyte device.
[0019] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the first analyte device includes a first light source configured to emit a first measuring light, a first sensor located on the surface of the target object, and a first processing module; the first sensor receives a first reflected light, a first transmitted light, or a first scattered light corresponding to the first measuring light; the first processing module is configured to obtain the first measurement data and the third measurement data based on the first measuring light and the received light, and output at least one of the following based on the calibration relationship: calibrated analyte level, analyte change trend, analyte abnormality alert, and analyte control evaluation.
[0020] Additionally, in the medical device system according to the first aspect of this disclosure, optionally, the processing device is configured to extract multiple continuous feature vectors from the first measurement data within the first time period using a sliding time window, and pair the multiple continuous feature vectors with the continuous analyte values, analyte change rates, or analyte trend labels within the corresponding time windows in the second analyte data, in order to train or update an individualized calibration model.
[0021] Additionally, in the medical device system disclosed in the first aspect, the calibration relationship may optionally include a mapping model, calibration coefficient, offset, proportionality coefficient, time delay parameter, feature weight, or a combination thereof.
[0022] In addition, in the medical device system disclosed in the first aspect, optionally, the calibration relationship includes a global calibration relationship and a local calibration relationship. The global calibration relationship is used to process the basic state data within the second time period, and the local calibration relationship is used to process data corresponding to post-meal, exercise, sleep, sweating, poor contact, or changes in wearing position.
[0023] A second aspect of this disclosure provides a method for acquiring analyte level information, comprising: acquiring continuous first measurement data of a target object within a first time period using a first analyte device; acquiring continuous second analyte data of the target object within the first time period using a second analyte device, wherein the second analyte device is a continuous analyte monitoring device; determining a calibration relationship based on the temporal correspondence between the first measurement data and the second analyte data at multiple times; acquiring continuous third measurement data within a second time period after the first time period using the first analyte device; and processing the third measurement data based on the calibration relationship to obtain calibrated analyte level information.
[0024] Additionally, in the acquisition method according to the second aspect of this disclosure, optionally, determining the calibration relationship includes at least one of the following: training a regression model based on photoplethysmography signals and the second analyte data; updating the coefficients of the partial least squares model based on near-infrared spectral signals and the second analyte data; segmenting the second analyte data based on events, environmental characteristics, or contact states, and determining sub-calibration relationships for each segment.
[0025] A third aspect of this disclosure provides an electronic device or a computer-readable storage medium, the electronic device including a processor and a memory, or the computer-readable storage medium storing a program; when the program is executed by the processor, it implements the acquisition method involved in the second aspect of this disclosure.
[0026] According to this disclosure, a medical device system, related method, device, and medium are provided that can perform individualized calibration of non-invasive or low-invasive analyte devices using continuous reference data, thereby improving the accuracy of subsequent analyte level information acquisition. Attached Figure Description
[0027] This disclosure will now be explained in further detail by way of example only with reference to the accompanying drawings, in which:
[0028] Figure 1 is a schematic diagram illustrating an application scenario of a medical device system including a first analyte device and a second analyte device as described in this disclosure.
[0029] Figure 2 is an exemplary flowchart illustrating the acquisition method involved in this disclosure.
[0030] Figure 3 is an exemplary flowchart illustrating step S104 based on the mapping relationship involved in the example of this disclosure.
[0031] Figure 4 is an exemplary flowchart illustrating step S104 based on the calibration coefficient as described in this disclosure example.
[0032] Figure 5 is an exemplary flowchart illustrating the calibration process related to target features as described in this disclosure.
[0033] Figure 6 is an exemplary flowchart illustrating a calibration process related to the setup location as described in this disclosure.
[0034] Figure 7 is an exemplary overall implementation diagram illustrating the medical device system involved in the examples of this disclosure.
[0035] Figure 8 is an exemplary block diagram illustrating the first analyte apparatus according to an example of this disclosure.
[0036] Figure 9 is an exemplary block diagram illustrating the detection module involved in the example of this disclosure.
[0037] Figure 10A is a schematic diagram illustrating the smartwatch that is an example of the present disclosure.
[0038] Figure 10B is an exemplary block diagram illustrating a smartwatch according to an example of this disclosure.
[0039] Figure 11 is a schematic diagram illustrating the volume unit involved in the example of this disclosure.
[0040] Figure 12 is an overview diagram illustrating the application of the continuous analyte monitoring system according to the examples of this disclosure.
[0041] Figure 13 is a schematic diagram showing the assembly of the unit and the application device on the pre-use body according to an example of this disclosure.
[0042] Figure 14 is a block diagram illustrating an electronic device of a body unit according to an example of this disclosure. Detailed Implementation
[0043] Hereinafter, preferred embodiments of the present disclosure will be described in detail with reference to the accompanying drawings. In the following description, the same reference numerals are used for the same components, and repeated descriptions are omitted. Furthermore, the drawings are merely schematic diagrams, and the proportions of the components or the shapes of the components may differ from actual figures.
[0044] It should be noted that the terms "comprising" and "having" and any variations thereof in this disclosure, such as a process, method, system, product, or device that includes or has a series of steps or units, are not necessarily limited to those steps or units that are explicitly listed, but may include or have other steps or units that are not explicitly listed or that are inherent to such processes, methods, products, or devices.
[0045] First, let me introduce the relevant terminology used in this disclosure.
[0046] "Target subject" can refer to any organism that needs to monitor analytes in bodily fluids. For example, a target subject could be a user who needs to manage their weight by monitoring changes in blood glucose levels. Another example is a diabetic patient who needs to monitor changes in blood glucose levels.
[0047] "Analytical equipment" can refer to equipment used to monitor analytes in the bodily fluids of a target object.
[0048] "Basic state data" can refer to measurement data under normal circumstances.
[0049] A "personalized calibration model" can refer to a calibration model tailored to a specific individual. A personalized calibration model can receive information related to a third measurement to output calibrated analyte level information. A personalized calibration model can be trained or updated using information related to the first measurement and second analyte data.
[0050] "Temperature compensation features" can refer to feature data used to compensate for the impact of temperature on non-invasive detection.
[0051] "Contact status characteristics" can refer to characteristic data that reflects the contact status between the first analyte device and the surface of the target object.
[0052] "Weighted update" can refer to combining the calibration relationships corresponding to the quality indicators of the data with different weights.
[0053] "Pause updates" can refer to temporarily stopping the updating of calibration relationships when data quality indicators do not meet the requirements.
[0054] "Analytic control evaluation" can refer to information that assesses the control status of analytes.
[0055] "Low analyte status" can refer to a state where the analyte level is in a low range.
[0056] "High analyte status" can refer to an indicator that the analyte level is in a high range.
[0057] "Fitted sample" can refer to a data sample used to fit the parameters of a mapping model.
[0058] "Trend segment matching" can refer to aligning and matching data segments with similar trends in the first measurement data and the second analysis data.
[0059] "Invasive device" can refer to a device that is at least partially implanted under the skin of a target subject to monitor analytes in the target subject's bodily fluids.
[0060] A "non-invasive device" can refer to a device that monitors analytes in the body fluids of a target subject without causing damage to the target subject's tissues. In some examples, a non-invasive device can be a device that uses technologies such as optics, microwaves, radio frequency, or ultrasound to monitor analyte levels. Taking optical technology as an example, a non-invasive device can use near-infrared or mid-infrared spectroscopy to emit light of a specific wavelength onto the surface of the target subject. The light of that specific wavelength is reflected by the target subject and can be received by the optical sensor of the non-invasive device. The analyte level of the target subject is obtained by measuring the absorption or scattering of light at that specific wavelength.
[0061] In some examples, the optical techniques may also include photoplethysmography-based detection techniques. The photoplethysmography signal may include AC and DC components caused by changes in blood volume, pulse wave, tissue scattering, and absorption of the target object. A first analyte device may extract pulse amplitude, rise time, fall time, waveform area, frequency domain energy, ratios of different wavelength channels, the ratio of AC to DC components, and compensation features related to temperature or contact state from the photoplethysmography signal of one or more wavelength channels, and incorporate these features as part of a first or third measurement.
[0062] In some examples, the optical techniques may also include at least one of near-infrared spectroscopy, short-wave infrared spectroscopy, mid-infrared spectroscopy, Raman spectroscopy, transmission spectroscopy, reflectance spectroscopy, diffuse reflectance spectroscopy, or transmissive-reflectance spectroscopy. The first analyte device can obtain absorption, reflection, scattering, or interferograms in specific spectral bands and obtain initial analyte data or optical characteristics through filtering, baseline correction, scattering correction, spectral band selection, principal component analysis, partial least squares regression, neural networks, or other mathematical models.
[0063] This disclosure provides a medical device system that improves the accuracy of analyte level information by combining the advantages of multiple analyte devices. Specifically, the medical device system may include a first analyte device and a second analyte device. During a certain period, both the first and second analyte devices can be used simultaneously to identify the relationship between their analyte data during that period. During another period, only the first analyte device can be used, combined with the identified relationship, to analyze the analyte data from the first analyte device for that period to determine the analyte level information corresponding to the analyte data (e.g., interpreting the analyte data to determine analyte fluctuation information). This improves the accuracy of analyzing the analyte data from the first analyte device (i.e., improves the accuracy of the analyte level information).
[0064] In other words, according to the medical device system, the target can remove the second analyte device after using the first analyte device and the second analyte device simultaneously for a period of time, and continue to use the first analyte device. The analyte level information corresponding to the analyte data obtained during the period of simultaneous use can be obtained by utilizing the relationship between the analyte data obtained during the period of continued use of the first analyte device.
[0065] In addition, the medical device system disclosed herein may also be referred to as a medical device device or an analytical substance monitoring system, etc.
[0066] This disclosure also provides a method for acquiring analyte level information using a first analyte device (hereinafter referred to as an acquisition method or a method for determining analyte level information), which is an acquisition method based on a second analyte device.
[0067] The analyte devices (e.g., a first analyte device and a second analyte device) disclosed herein can continuously monitor the analyte levels in the body fluids of a target subject.
[0068] The analyte involved in this disclosure may be glucose. The analyte involved in this disclosure may also be other analytes besides glucose concentration. Examples include blood ketones, acetylcholine, amylase, bilirubin, cholesterol, creatine kinase, creatine, creatine anhydride, DNA, fructosamine, analytes, glutamine, hormones (e.g., growth hormone, human chorionic gonadotropin, or thyroid-stimulating hormone), ketone bodies, lactate, peroxides, prostate-specific antigen, prothrombin, RNA, or troponin, etc.
[0069] For ease of description, some examples below use a first analyte device as a non-invasive analyte monitoring device (hereinafter referred to as a non-invasive device), which is a device that uses optical technology to monitor analyte levels, and a second analyte device as an invasive analyte monitoring device (hereinafter referred to as an invasive device). It should be noted that this does not imply any limitation on this disclosure. Unless there is a contradiction, some descriptions also apply to the first analyte device and the second analyte device. For example, the first analyte device and the second analyte device can be non-invasive devices or invasive devices with different implementations.
[0070] Figure 1 is a schematic diagram illustrating an application scenario of a medical device system including a first analytical device 1 and a second analytical device 2 as described in this disclosure. The first analytical device 1 is an example of a non-invasive device, and the second analytical device 2 is an example of an invasive device. This does not imply any limitation on this disclosure.
[0071] Referring to Figure 1, the first analyte device 1 can be installed on the skin of the target object and acquire analyte data in a non-invasive manner. The second analyte device 2 can be installed on the skin of the target object, and at least a portion of it can be located under the skin of the target object (i.e., the second analyte device 2 can acquire analyte data invasively). By performing the acquisition method according to the example of this disclosure, the analyte data acquired by the first analyte device 1 can be analyzed based on the analyte data acquired by the second analyte device 2 to obtain the corresponding analyte level information. This improves the accuracy of the analyte level information.
[0072] In various examples of this disclosure, the first analyte device 1 and the second analyte device 2 can be used simultaneously for at least a period of time. In some examples, the second analyte device 2 can be used for a period of time during the use of the first analyte device 1. In some examples, the second analyte device 2 and the first analyte device 1 can be used simultaneously. In some examples, the duration of the simultaneous use period can be the usage period of the second analyte device 2. In this case, the amount of data used to determine subsequent target relationships can be increased, noise interference can be reduced, and the accuracy and generalization ability of identifying target relationships can be improved.
[0073] Figure 2 is an exemplary flowchart illustrating the acquisition method involved in this disclosure.
[0074] In some examples, referring to Figure 2, the acquisition method may include: acquiring continuous first measurement data of the target object over a first time period acquired by the first analyte device 1 (step S101); acquiring continuous second analyte data of the target object over a first time period acquired by the second analyte device 2 (step S102); acquiring continuous third measurement data of the target object over a second time period acquired by the first analyte device 1 after the first time period (step S103); and acquiring calibrated analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data (hereinafter referred to as the target relationship) (step S104). In this case, by combining the data prior to the first analyte device 1 with the relationship between the analyte data of the second analyte device 2 and the data of the first analyte device 1, the advantages of multiple analyte devices can be combined, thereby improving the accuracy of the analyte level information corresponding to the analyte data while continuously monitoring the analyte. In addition, obtaining analyte level information by utilizing the relationship determined by the analyte data of the two analyte devices in the first time period in the second time period helps to reduce the dependence on the second analyte device 2 in the second time period (that is, the advantages of the second analyte device 2 are utilized, but the second analyte device 2 does not need to be used all the time).
[0075] In some examples, referring to Figure 2, in steps S101 and S102, the first analyte device 1 and the second analyte device 2 can be two analyte devices with different implementations. In this case, the two analyte devices have different advantages. By combining the advantages of the two analyte devices through the schemes involved in the examples of this disclosure, the accuracy of the analyte level information corresponding to the analyte data can be improved.
[0076] Furthermore, the implementation method can be any way that causes differences in the analyte data between the two analyte devices. For example, the implementation method can include at least one of the following: monitoring principle, monitoring frequency, manufacturer, and device version.
[0077] In some examples, the relationship between the first analyte device 1 and the second analyte device 2 can satisfy at least one of the following:
[0078] Option 1: The monitoring frequency of the second analyte device 2 can be greater than that of the first analyte device 1. In this case, the advantages of both analyte devices are combined to improve the accuracy of analyte level information, while supporting an increase in the monitoring frequency without changing the usage of the first analyte device 1.
[0079] The second approach involves using a device 1 (the first analyte) with a lifespan longer than the device 2 (the second analyte). In this case, the advantages of both devices are combined to improve the accuracy of analyte level information while also extending the monitoring duration.
[0080] The third approach: The operating cost of the first analyte device 1 can be lower than that of the second analyte device 2. In this case, the advantages of both analyte devices can be combined to improve the accuracy of analyte level information while reducing monitoring costs.
[0081] Fourthly, the second analytical device 2 can be an invasive device, and the first analytical device 1 can be a non-invasive device. The non-invasive device can be located on the skin of the target object. At least a portion of the invasive device can be located subcutaneously. As mentioned above, while invasive devices are more accurate than non-invasive devices, they are generally painful. In this case, combining the advantages of both analytical devices can improve the accuracy of analytical level information while enhancing the user experience.
[0082] As described above, the first measurement data and the second analyte data can be analyte data of the target object within a first time period. For example, within the first time period, the target object can simultaneously wear the first analyte device 1 and the second analyte device 2 to obtain the first measurement data and the second analyte data with a time correspondence. This facilitates the determination of the target relationship. In other examples, the first measurement data and the second analyte data may not be analyte data from the same time period; for example, they can be any related analyte data.
[0083] In some examples, the first time period may include at least a portion of multiple time periods. In this case, it facilitates the identification of outlier data, thereby reducing the impact of outlier data on identifying target relationships. Additionally, periodic data can capture patterns of data change over time, facilitating subsequent analysis of the accuracy of analyte level information corresponding to the third measurement data. For example, if multiple days of blood glucose data identify that a target subject is prone to hypoglycemia at 5 AM daily, and if the analyte level information corresponding to the third measurement data deviates from the previously identified information, it can confirm whether the analyte level information is incorrect. In some examples, the time period can be one day.
[0084] As described above, the first measurement data and the second analyte data can also be any related analyte data. In some examples, the monitoring time of the first measurement data and the monitoring time of the second analyte data can be based on an event correspondence. That is, the first measurement data and the second analyte data can be measured during the same event. For example, the monitoring time of the first measurement data and the monitoring time of the second analyte data can be a feeding time. In this case, it is convenient to analyze the analyte data of the first analyte device 1 by utilizing the pattern of analyte level changes during the same event.
[0085] In some examples, for the second analyte device 2, which is an invasive device, the first time period can be the time period after the target subject has used the second analyte device 2 for a predetermined period. For example, the second analyte data is obtained from the second analyte device 2 after the target subject has used it for thirty minutes or one hour. In this case, analyte data measured by the second analyte device 2 under stable operating conditions can be obtained, thereby improving the accuracy of subsequent processing.
[0086] In some examples, referring to Figure 2, in step S103, the first measurement data and the third measurement data can be analyte data from different time periods (i.e., initial analyte data). For example, the third measurement data can be analyte data measured when the target object is only wearing the first analyte device 1. This helps reduce reliance on the second analyte device 2. In some examples, when the first measurement data and the third measurement data are analyte data, the first measurement data can be referred to as the first analyte data, and the third measurement data can be referred to as the third analyte data.
[0087] In some examples, the first and third measurement data can also be any data related to the analyte data (e.g., the original detection signal and / or feature data obtained from the original detection signal). Some of the following examples are described using the first and third measurement data as initial analyte data. It should be noted that this does not imply limitation of the disclosure, and the related descriptions, unless contradictory, can be equally applied to other data such as the original detection signal and / or feature data obtained from the original detection signal.
[0088] Furthermore, in various examples of this disclosure, the first measurement data, the second analyte data, and the third measurement data can be data related to the same analyte. For example, the first measurement data, the second analyte data, and the third measurement data can all be glucose data or blood ketone data. This facilitates the identification of relationships between the analyte data. Additionally, the analyte data can include at least one analyte level. For example, glucose data can include at least one glucose concentration value. Continuous analyte data can refer to analyte data collected by the analyte device at predetermined time intervals.
[0089] The first measurement data can be analyte data for a first time period acquired by the first analyte device 1, the third measurement data can be analyte data for a second time period acquired by the first analyte device 1, and the second analyte data can be analyte data for a first time period acquired by the second analyte device 2.
[0090] In some examples, referring to Figure 2, in step S104, the analyte level information can be any information that can be obtained from the third measurement data and is related to the analyte level. In some examples, the analyte level information can include at least one of the analyte data itself (e.g., the analyte level) and evaluation data of the analyte data (e.g., analyte fluctuation information, analyte control information, or risk level). In some examples, the analyte level information can include at least one of the calibrated third measurement data (also referred to as the target analyte level), analyte fluctuation information, analyte control information, and analyte statistics (e.g., the average analyte level). In some examples, the analyte level information can also include at least one of low analyte state, high analyte state, and analyte change trend.
[0091] In addition, the target relationship can be related to the difference in analyte data between the first analyte device 1 and the second analyte device 2. The target relationship can be determined by analyzing the first measurement data and the second analyte data.
[0092] In some examples, the target relationship can include at least one of correlation, environmental dependence, and calibration. A correlation (e.g., a linear or non-linear relationship) can refer to a statistical correlation between data collected by two devices. An environmental dependence can refer to a correlation between data collected by two devices due to the influence of the same environmental characteristics. A calibration relationship can refer to a situation where data from one device can be used as a reference to calibrate data from another device.
[0093] In some examples, calibration relationships may include mapping models, calibration coefficients, offsets, scaling factors, time delay parameters, feature weights, or combinations thereof. In some examples, calibration relationships may include global calibration relationships and local calibration relationships. Global calibration relationships are used to process baseline state data within a second time period, while local calibration relationships are used to process data corresponding to post-meal, exercise, sleep, sweating, poor contact, or changes in wearing position.
[0094] In some examples, when the monitoring frequency of the second analyte device 2 is greater than that of the first analyte device 1 (e.g., the second analyte device 2 collects high-frequency data, and the first analyte device 1 collects low-frequency data), the target relationship can be represented by interpolated data between the analyte levels at two time points determined by the second analyte data for the first measurement data. This facilitates the acquisition of high-frequency analyte data using a low-frequency analyte device.
[0095] In some examples, when the accuracy of the second analyte device 2 is greater than that of the first analyte device 1, the calibration relationship may include a mapping relationship between the target information of the first measurement data and the target information of the second analyte data. For example, the mapping relationship can be obtained by analyzing the second and first analyte data using methods such as statistical analysis, curve fitting, or machine learning. In this case, the mapping relationship can reveal the correlation between the two sets of data, thereby improving the accuracy and generalization ability of identifying the target relationship. In some examples, the mapping relationship may include at least one of key-value pair mapping, functional mapping, and machine learning model-based mapping. In some examples, the target information in the first measurement data and the target information in the second analyte data can be used as training samples or fitting samples to establish a mapping model, and the calibrated analyte level information corresponding to the third measurement data can be determined based on the mapping model. For example, the calibrated analyte level information may include at least one of the following: target analyte level, analyte change trend, low analyte state (e.g., hypoglycemia), high analyte state (e.g., hyperglycemia), and analyte fluctuation information.
[0096] Figure 3 is an exemplary flowchart illustrating step S104 based on the mapping relationship involved in the example of this disclosure.
[0097] In some examples, when the accuracy of the second analyte device is greater than that of the first analyte device, and the target relationship is a mapping relationship, the analyte level information can include first information, which can be related to the target information of the mapped third measurement data. That is, the target information of the third measurement data can be mapped to new target information through the mapping relationship. In this case, the accuracy of the analyte level information obtained by the first analyte device 1 can be improved.
[0098] In some examples, when the target relationship is a mapping relationship, referring to Figure 3, step S104 may include establishing the mapping relationship (step S201) and determining the target information of the third measurement data mapped via the mapping relationship based on the mapping relationship (step S202). This improves the accuracy of the target information.
[0099] Furthermore, referring to Figure 3, in steps S201 and S202, the target information for the analyte data (e.g., the first measurement data, the second analyte data, and the third measurement data) can be information obtained from the analyte data and used when acquiring analyte level information. That is, the target information is related to the specific analyte level information that needs to be obtained. For example, if the analyte level information includes analyte control information (e.g., good blood glucose control or poor blood glucose control), the target information can include information on the fluctuation of analyte levels over time (i.e., analyte fluctuation information). This facilitates the acquisition of analyte control information from the analyte fluctuation information.
[0100] In some examples, the target information may include at least one of single-point analyte levels, multi-point continuous analyte levels (i.e., analyte levels over a period of time), and analyte fluctuation information. The specific target information can be selected as needed. For example, if it is necessary to monitor blood glucose fluctuations, the target information can be set to analyte fluctuation information to obtain more accurate analyte fluctuation data. As another example, if it is necessary to monitor analyte data over a specific time period, the target information can be set to multi-point continuous analyte levels. Yet another example, if it is necessary to obtain analyte levels at each point or to use each analyte level for further processing, the target information can be set to single-point analyte levels.
[0101] In some examples, in step S201, a mapping relationship can be established based on the target information of the first measurement data and the target features within the first time period. That is, the target information of the first measurement data and the target features within the first time period can participate in determining the mapping relationship. This allows for a more accurate mapping relationship to be obtained.
[0102] For example, in key-value pair mappings, target information and target features can serve as keys, and the mapped target information can serve as values. Similarly, in functional mappings, target information and target features can serve as inputs to a function, and the mapped target information can serve as the function's output. Furthermore, in machine learning model-based mappings, target information and target features can serve as inputs to the machine learning model (i.e., target features can participate in the model's training), and the mapped target information can serve as the model's output. Additionally, in identifying mapping relationships, the mapped target information can be the target information of the second analyte data or information that approximates the target information of the second analyte data. For example, in machine learning model-based mappings, the target information of the second analyte data can be the labels of training samples, and training allows the machine learning model's output to approximate the target information of the second analyte data.
[0103] Additionally, the target feature can be a feature that is repeatable within the second time period and is related to changes in analyte levels. In some examples, the feature related to changes in analyte levels can be a feature that influences the analyte and / or a pattern of analyte variation. That is, the feature related to changes in analyte levels can be a factor affecting the analyte level and / or a data feature appearing in the analyte data. In some examples, the target feature can include at least one of an event, data features of the first measurement data, and environmental features.
[0104] In some examples, the target features can be user-defined. This makes it easier to make the information determined by the target features (such as mapping relationships or calibration information described later) more closely match the target object itself.
[0105] In some examples, the target features can be user-undefined. This reduces the risk that inaccurate target features, resulting in inaccurate information determined by those features, could be due to user error.
[0106] In some examples, target features may include a user-customizable first target feature and a user-non-customizable second target feature. In this case, being able to consider both general and personalized target features simultaneously can improve the accuracy and relevance of the identified information.
[0107] In some examples, the event may be associated with the target's behavior and / or physical condition. In some examples, the event may include at least one of diet, exercise, medication, sleep, and physical condition. Additionally, physical condition can be any physiological and / or psychological factor that can cause changes in analyte levels. For example, psychological stress can cause the body to release stress hormones (such as adrenaline and cortisol), leading to elevated blood sugar. Similarly, mood swings (such as anxiety and depression) may cause fluctuations in blood sugar.
[0108] In addition, data characteristics can be the patterns of analyte level changes identified from analyte data (e.g., first measurement data).
[0109] In some examples, the types of data features may be known before the target relationship is determined. For instance, the types of data features can be determined by classifying the changes in analyte levels in the sample analyte data. That is, the types of data features common in different sample target objects are analyzed to determine the types of data features. Additionally, the sample analyte data can be the analyte data of the sample target objects. The sample target objects can refer to individuals or groups selected to represent the population in a study, survey, experiment, or statistical analysis.
[0110] In some examples, the types of data features can be dynamic. For instance, data features in the first measurement data can be clustered to determine the types of data features for the analyte data of each target object. This allows for obtaining a more tailored set of data features for each target object.
[0111] Furthermore, the environmental characteristics can be any characteristics related to environmental factors. That is, the environmental characteristics can be related to the environment at the location where the first analyte device 1 is set. For example, the environmental characteristics can include at least one of contact status, temperature information, and humidity information (e.g., the amount of sweat on the target object's skin). This reduces the influence of environmental characteristics on the analyte level. Additionally, the contact status can indicate whether the first analyte device 1 is in close contact with the target object. For example, the contact status can be represented by the pressure value on the target object's skin or the impedance between the first analyte device 1 and the target object.
[0112] In some examples, target features may include at least one of diet, exercise, medication, sleep, physical condition, data waveform morphology, rate of change, temperature, humidity, contact status, and wearing position.
[0113] In some examples, a calibration relationship can be determined based on the correspondence between first measurement data and second analyte data at multiple times within a first time period, and the third measurement data can be processed based on the calibration relationship to obtain calibrated analyte level information.
[0114] Additionally, the correspondence can refer to the data pairing relationship between first measurement data and second analyte data at multiple points within a first time period. In some examples, the correspondence can be a time-series correspondence, that is, the correspondence between the first measurement data and the second analyte data in the time dimension.
[0115] In some examples, determining calibration relationships includes at least one of the following: training a regression model based on photoplethysmography signals and continuous analyte data (i.e., second analyte data); updating the coefficients of the partial least squares model based on near-infrared spectral signals and continuous analyte data; and segmenting the continuous analyte data based on events, environmental characteristics, or contact states and determining sub-calibration relationships for each segment.
[0116] In some examples, the calibration relationship can be constrained based on trend information from the second analyte data. In some examples, the trend information may include at least one of an upward trend, a downward trend, a stationary trend, a rate of change, an acceleration of change, a post-meal peak, a nighttime low, and time within the target range.
[0117] In some examples, the calibration relationship can be weighted and updated or paused based on the quality indicators of the first measurement data and / or the second analyte data. This reduces the impact of data quality on the accuracy of analyte level information.
[0118] In some examples, multiple sub-calibration relationships can be determined based on the target features in the first time period, and in response to the identification of features that are the same as or match the target features in the second time period, the corresponding sub-calibration relationship can be invoked to process the third measurement data.
[0119] Figure 4 is an exemplary flowchart illustrating step S104 based on the calibration coefficient as described in this disclosure example.
[0120] In some examples, the calibration relationship can be represented using at least one calibration coefficient. In some examples, when the accuracy of the second analyte device is greater than that of the first analyte device, and the calibration relationship is represented using a calibration coefficient, the analyte level information can include second information, which can be information related to the calibrated third measurement data. For example, the second information can be the calibrated third measurement data itself, or it can be information derived from the calibrated third measurement data.
[0121] In some examples, when the calibration relationship is represented using at least one calibration coefficient, referring to Figure 4, step S104 may include calibrating the first analyte data based on the second analyte data to obtain at least one calibration coefficient (step S301), and calibrating the third measurement data based on the at least one calibration coefficient to obtain calibrated third measurement data (step S302). This simplifies the process of obtaining the calibration relationship. Furthermore, obtaining the calibrated analyte level through the calibration coefficient helps improve the diversity of analyses based on the calibrated analyte level. That is, after obtaining the most basic calibrated analyte level, corresponding analyses can be performed as needed, such as analyzing analyte fluctuations or analyte control, identifying low or high analyte levels, etc., based on the calibrated analyte level.
[0122] In some examples, referring to Figure 4, in step S301, calibration coefficients for adjusting the first measurement data to make it close to or consistent with a standard value can be determined by calibrating the first measurement data. Alternatively, the standard value can be the analyte level in the second analyte data, or it can be a known value determined by the second analyte data (e.g., the baseline value of the target object determined by the second analyte data (i.e., the range of analyte levels the target object should be in)).
[0123] In some examples, the calibration factor can be the difference between the second analyte data and the first measurement data. In other examples, the calibration factor can be the ratio between the second analyte data and the first measurement data.
[0124] In some examples, calibration coefficients can be stored. For instance, calibration coefficients can be stored in the memory of the first analyte device 1 or the memory of the processing device 3, which will be described later. In this case, it is convenient to calibrate the analyte data subsequently obtained by the first analyte device 1.
[0125] In some examples, the first analyte device 1 may include at least one light source and a photoelectric sensor for acquiring photoplethysmography (PPG) signals. During a first time period, the first analyte device 1 acquires PPG signals from multiple wavelength channels at a predetermined sampling frequency, and the second analyte device 2 outputs analyte values in a continuous analyte monitoring manner.
[0126] In some examples, multiple continuous feature vectors (i.e., multiple target features) are extracted from the first measurement data using a sliding time window within a first time period. These continuous feature vectors are then paired with continuous analyte values, analyte change rates, or analyte trend labels within the corresponding time window in the second analyte data to train or update the individualized calibration model. This enables the individualized calibration model to calibrate continuous analyte values, analyte change rates, or analyte trends.
[0127] In some examples, the photoplethysmography (PPG) signal can be filtered, pulse cycle segmented, and quality assessed first. Then, features such as AC component, DC component, AC / DC ratio, pulse wave rise slope, fall slope, waveform area, heart rate, temperature, and contact pressure can be extracted within a sliding time window. These features can then be paired with time-aligned second analyte data, and an individualized calibration model can be trained based on linear regression, random forest, gradient boosting models, neural networks, or combinations thereof. Upon entering the second time period, the same type of features extracted from the third measurement data are input into this individualized calibration model to obtain calibrated glucose levels and glucose change trends.
[0128] As a second example, the first analyte device 1 may include a near-infrared or mid-infrared spectroscopy module. During a first time period, the first analyte device 1 acquires the reflectance spectrum, transmission spectrum, diffuse reflectance spectrum, or interferogram of the target object's surface, while the second analyte device 2 acquires continuous glucose data. Dark current correction, normalization, baseline correction, scattering correction, and spectral band selection can be performed on the spectral data, selecting spectral bands related to glucose absorption or spectral features obtained through digital filtering. The spectral features can be used as a sample of the time-aligned second analyte data, and individualized regression coefficients can be determined using partial least squares regression, multiple linear regression, or regularized regression. Therefore, even if the second analyte device 2 is not used further during the second time period, the individualized regression coefficients can be used to calibrate the spectral features in the third measurement data.
[0129] In some examples, the second analyte data can be used to perform state-based calibration on the first analyte device 1. Specifically, within a first time period, trend segments such as rapid rise after meals, decline after exercise, stable at night, low glucose risk, or high glucose risk are identified based on the second analyte data. These trend segments are then combined with the temperature, humidity, contact status, motion signal, and wearing position detected by the first analyte device 1 to divide the trend segments and corresponding first measurement data into multiple state sets. Sub-calibration relationships can be established for different state sets, and confidence levels or applicable conditions can be configured for each sub-calibration relationship. Upon entering the second time period, if the temperature, humidity, contact status, motion signal, or waveform characteristics corresponding to the third measurement data meet a certain applicable condition, the corresponding sub-calibration relationship is invoked; if multiple applicable conditions are met simultaneously, the final calibration result can be determined according to confidence level, priority, or weighted fusion.
[0130] Figure 5 is an exemplary flowchart illustrating the calibration process related to target features as described in this disclosure.
[0131] In some examples, calibration coefficients can be determined in conjunction with target features, and the determined calibration coefficients are used to calibrate the third measurement data. Therefore, examples of this disclosure also provide a calibration process related to target features.
[0132] In some examples, referring to Figure 5, the calibration process may include, while calibrating the first measurement data, associating the target feature with the corresponding calibration coefficient in response to the identification of a target feature within a first time period (step S401). That is, when calibrating the first measurement data to obtain calibration coefficients, if the appearance of a target feature is identified, the target feature can be associated with the calibration coefficient. For example, if the target object is identified as moving while calibrating the first measurement data, the calibration coefficient can be associated with the motion event. In this case, the target feature and the corresponding calibration coefficient can be associated simultaneously with the calibration of the first measurement data, thereby facilitating subsequent calibration of other analyte data based on the target feature.
[0133] As described above, calibration coefficients can be saved. In some examples, a data list can be created to save calibration information, which may include calibration coefficients and target features associated with those coefficients. This facilitates subsequent retrieval of calibration coefficients from the data list. In some examples, the calibration information may also include the setting location associated with the calibration coefficients (described later).
[0134] In some examples, referring to Figure 5, the calibration process may include calibrating third measurement data based on calibration coefficients associated with the target feature (step S402). Specifically, when calibrating the third measurement data, in response to the identification of the target feature, the third measurement data is calibrated based on calibration coefficients associated with that target feature. In this case, the accuracy of the calibration coefficients can be improved, thereby improving the accuracy of the calibration.
[0135] In some examples, calibration coefficients can be obtained from the correlation between calibration coefficients and target features based on target features identified in the third measurement data (hereinafter referred to as identification results). In some examples, calibration coefficients can be obtained by querying a data list based on the identification results (e.g., identified events, data features of the first measurement data, and / or environmental features). For example, when target features such as a moving object and humidity information greater than 80% are identified, calibration coefficients associated with both moving object and humidity information greater than 80% can be queried from the data list.
[0136] In some examples, if no associated calibration coefficient is found from the association based on the identification results, at least one feature combination of the target features in the identification results can be determined, and the associated calibration coefficient can be determined based on the feature combination.
[0137] In some examples, the number of target features in each feature combination can be less than the number of target features in the recognition result. In this case, the probability of finding the calibration coefficient can be increased. In some examples, the number of target features in the feature combination can be reduced by 1 each time at least one feature combination is determined. For example, if no calibration coefficient is found based on the recognition result, the number of target features in the first determined feature combination can be the number of target features in the recognition result minus 1. If no calibration coefficient is found based on the first determined feature combination, the number of target features in the next determined feature combination can be the number of target features in the recognition result minus 2 (that is, the number of target features in the previous feature combination minus 1), and so on, until the calibration coefficient is found. In this case, as many target features as possible can be used to find the calibration coefficient in each query, thereby obtaining a relatively suitable calibration coefficient.
[0138] For example, when three target features (i.e., the recognition result) are identified simultaneously, and no calibration coefficient corresponding to all three target features is found in the data list based on the recognition result, the calibration coefficient corresponding to the combination of the three target features can be found in the data list. In the first combination, the number of target features is 1 less than the number of target features in the recognition result.
[0139] In some examples, if no associated calibration coefficient is found from at least one calibration coefficient based on the identification results, the associated calibration coefficient can be determined based on the priority of the target features in the identification results. In this case, determining the calibration coefficient based on the priority of multiple target features can improve the flexibility of determining the calibration coefficient. For example, the priority of different target features can be determined by analyzing historical data.
[0140] For example, when three target features (i.e., recognition results) with increasing priority are identified simultaneously, and no calibration coefficient corresponding to all three target features is found in the data list based on the recognition results, the calibration coefficient corresponding to the third feature with the highest priority is used to search the data list.
[0141] In other examples, the associated calibration coefficients can also be determined initially based on the priority of the target features in the identification results. Specifically, after the identification results are determined, the associated calibration coefficients are determined based on the priority of the target features in the identification results.
[0142] In some examples, calibration coefficients can be determined based on the placement position of the first analyte device 1 on the target object, and the determined calibration coefficients can be used to calibrate the third measurement data. Therefore, examples of this disclosure also provide a calibration process related to the placement position.
[0143] Figure 6 is an exemplary flowchart illustrating a calibration process related to a setup location as described in this disclosure. In some examples, referring to Figure 6, the calibration process may include associating at least one calibration coefficient (e.g., a set of calibration coefficients) with the setup location of the first analyte device 1 on the target object when calibrating the first measurement data (step S501). That is, each setup location may correspond to a set of calibration coefficients. In this case, the influence of different setup locations of the first analyte device 1 on the target object on the calibration coefficients can be reduced. In some examples, the setup location of the first analyte device 1 on the target object may be input by the target object.
[0144] In some examples, referring to FIG6, the calibration process may include determining at least one associated calibration coefficient based on the placement position of the first analyte device 1 on the target object when calibrating the third measurement data, and calibrating the third measurement data using the at least one associated calibration coefficient (step S502).
[0145] For example, when using two analyte devices simultaneously, the setup position of the first analyte device 1 can be recorded and associated with at least one set of calibration coefficients. This allows for the acquisition of multiple sets of calibration coefficients associated with the setup position. When one first analyte device 1 expires, another can be replaced, thus changing the setup position. When calibrating third measurement data, the corresponding set of calibration coefficients can be determined by combining the updated setup position (e.g., querying at least one calibration coefficient associated with the setup position previously determined when using the first analyte device 1 and the second analyte device 2 simultaneously).
[0146] In some examples, the first measurement data and the second analyte data can be timestamped before determining the target relationship. In this case, the impact of potential temporal shifts caused by the different sources of the first measurement data and the second analyte data can be reduced, improving the temporal matching between the two data and thus enhancing the accuracy of subsequent processing.
[0147] In some examples, before determining the target relationship, at least one of the following processes can be applied to the first measurement data and the second analyte data: sampling frequency matching, filtering, outlier removal, time delay estimation, and trend segment matching, so that the continuous data from the second analyte device 2 serves as individualized continuous reference data for the first analyte device 1.
[0148] Figure 7 is an exemplary overall implementation diagram illustrating the medical device system involved in the examples of this disclosure.
[0149] As described above, this disclosure also discloses a medical device system. In some examples, referring to FIG7, the medical device system includes a first analyte device 1 and a second analyte device 2. It should be noted that, unless there is a contradiction, the relevant description of the acquisition method described above also applies to the medical device system.
[0150] The first analyte device 1 can be configured to acquire measurement data of the target object (e.g., first measurement data and / or third measurement data), and the second analyte device 2 can be configured to acquire analyte data of the target object. In some examples, the second analyte device 2 can be a continuous analyte monitoring device.
[0151] In some examples, the first analyte device 1 can be configured to acquire measurement data of a target object in a non-invasive or low-invasive manner. In some examples, the measurement data acquired by the first analyte device 1 may include at least one of a raw detection signal (e.g., a raw electrical signal), feature data derived from the raw detection signal, and initial analyte data. Furthermore, the raw detection signal may refer to a signal (e.g., an optical or electrical signal) generated directly by an element in the first analyte device 1 sensitive to the analyte in response to the analyte. That is, an unprocessed sensor output signal directly acquired by the first analyte device 1. Additionally, the initial analyte data may refer to uncalibrated analyte data (e.g., analyte measurements). Furthermore, uncalibrated analyte data may be acquired based on the raw detection signal.
[0152] In some examples, the first analyte device 1 may include an optical analyte device. In some examples, when the first analyte device 1 may include an optical analyte device, the raw detection signal may include at least one of a photoplethysmography signal, a reflectance spectrum signal, a transmission spectrum signal, a diffuse reflectance spectrum signal, a light intensity signal, an absorption spectrum signal, and a scattering signal.
[0153] Additionally, the feature data can be features extracted from the original detection signal. In some examples, the feature data may include at least one of the following: intensity ratio of different wavelengths or channels, AC component, DC component, pulse waveform features, absorption peak features, spectral filtering features, temperature compensation features, and contact state features.
[0154] In some examples, the first analyte device 1 can be configured to acquire continuous first measurement data of the target object within a first time period. The second analyte device 2 can be configured to acquire continuous second analyte data of the target object within the first time period.
[0155] In some examples, when the analyte is glucose, the first analyte device 1 can be a continuous non-invasive glucose monitoring device. The continuous non-invasive glucose monitoring device can be configured to obtain glucose level information for a second time period using a calibration relationship determined by continuous glucose data from the continuous glucose monitoring device when the second analyte device is removed, deactivated, or not worn.
[0156] In some examples, the first analyte device 1 can also be configured to acquire third measurement data of the target object continuously over a second time period, following a first time period. Additionally, the first measurement data, the second analyte data, and the third measurement data can be the same analyte data.
[0157] In some examples, the medical device system can be configured to acquire calibrated analyte level information corresponding to a third measurement based on the relationship between the first measurement data and the second analyte data (hereinafter referred to as the acquisition step). For a description of the acquisition step, please refer to the description of step S104, which will not be repeated here.
[0158] Furthermore, the acquisition step can be performed by any device in the medical device system. In some examples, referring to FIG7, the medical device system may include a processing device 3 (e.g., a processor). The processing device 3 may be configured to perform the acquisition step. In some examples, the processing device 3 may be located at at least one of a first analyte device 1, a second analyte device 2, a mobile terminal, a reading device, and a server. In some examples, when the processing device 3 is located at a mobile terminal, a reading device, or a server, the processing device 3 may be configured to receive first measurement data and / or third measurement data from the first analyte device 1, and receive second analyte data from the second analyte device 2.
[0159] In some examples, the acquisition step can be performed by the first analytical device 1. This simplifies the structure of the medical device system.
[0160] Figure 8 is an exemplary block diagram illustrating the first analyte device 1 according to the example of this disclosure.
[0161] In some examples, referring to FIG8, the first analyte device 1 may include a first processing module 11, which may be configured to receive second analyte data and perform acquisition steps. In some examples, the first processing module 11 may be configured to output at least one of the following based on calibration relationships: calibrated analyte level, analyte change trend, analyte anomaly alert, and analyte control evaluation.
[0162] In some examples, referring to FIG8, the first analyte device 1 may further include a first light source 12 and a first sensor 13 located on the skin of the target object. The first light source 12 may emit a first measuring light. The first light source 12 may emit the first measuring light toward the surface of the target object. The first measuring light may be light in the near-infrared or mid-infrared spectral range. The first sensor 13 may receive a signal light corresponding to the first measuring light. The signal light may be any light carrying an analyte signal. In some examples, the signal light may include first reflected light, first transmitted light, and / or first scattered light.
[0163] In some examples, the first processing module 11 can obtain analyte data (e.g., first measurement data and third measurement data) based on the first measurement light and the received signal light. In some examples, the first processing module 11 can obtain the spectrum of the first reflected light. The first processing module 11 can obtain the light intensity corresponding to the absorption peak of the analyte based on the spectrum of the first reflected light. In some examples, the analyte data can be calculated based on the mathematical relationship between the light intensity and the analyte data. For example, the analyte data can be obtained by multiplying the light intensity by the conversion coefficient of the first analyte device 1. In some examples, the first conversion coefficient can be the sensitivity of the first analyte device 1. As described above, in some examples, the first processing module 11 can also obtain analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data (i.e., perform the acquisition step).
[0164] In some examples, referring to Figure 8, the first analyte device 1 may include a detection module 14. In some examples, the detection module 14 may be configured to acquire environmental characteristics of the environment in which the first analyte device 1 is located. In this case, combining environmental characteristics can improve the adaptability of the analyte data analysis, thereby improving the accuracy of the analyte level information corresponding to the analyte data.
[0165] Figure 9 is an exemplary block diagram illustrating the detection module 14 as described in this disclosure.
[0166] In some examples, the detection module 14 may include a contact detection module 141. The contact detection module 141 may be configured to detect the contact state between the first analyte device 1 and the target object.
[0167] In some examples, the contact detection module 141 may be at least one of a pressure sensor, a contact electrode, and an ultrasound module. In some examples, the pressure sensor may detect the pressure between the first analyte device 1 and the target object. In some examples, the contact electrode may detect the impedance between the first analyte device 1 and the target object. In some examples, the ultrasound module may detect contact parameters between the first analyte device 1 and the target object. Contact parameters may be contact area or tissue thickness, etc.
[0168] In some examples, the detection module 14 may include a temperature sensor 142, which can be configured to acquire temperature information. In some examples, the detection module 14 may include a humidity sensor 143, which can be configured to acquire humidity information. In some examples, the detection module 14 may include an accelerometer 144, which can be configured to acquire motion signals. In some examples, events can be identified based on motion signals.
[0169] Figure 10A is a schematic diagram illustrating a smartwatch 100 according to an example of this disclosure. Figure 10B is an exemplary block diagram illustrating a smartwatch 100 according to an example of this disclosure.
[0170] In some examples, referring to FIG10A, the first analytical device 1 may be a smartwatch 100 having a light source and sensors. In some examples, referring to FIG10B, the smartwatch 100 may include at least one of an optical sensing module 130, an analog front end 150, a control circuit 160, a processor 170, a glucose estimation algorithm 180, a power module 190, a wireless communication module 200, and a display / output module 112.
[0171] In some examples, the optical sensing module 130 can be used to acquire the user's optical detection signal. The optical sensing module 130 may include a green LED 134, an infrared LED 136, and a photodetector 138. The green LED 134 can emit green light with a wavelength of approximately 525 nm, and the infrared LED 136 can emit infrared light with a wavelength of approximately 940 nm. The photodetector 138 (PDs) can receive the light signal reflected or transmitted through the user's tissue and generate a corresponding electrical signal.
[0172] In some examples, the light emitted by the green LED 134 and the infrared LED 136 can illuminate the user's skin tissue. The blood, tissue fluid, and other physiological structures in the tissue can absorb, scatter, or reflect light of different wavelengths. In this case, the photodetector 138 can receive the reflected or transmitted light and output the corresponding photoelectric detection signal.
[0173] In some examples, the analog front-end 150 can be electrically connected to the optical sensing module 130. The analog front-end 150 can be used to condition the raw signal output from the photodetector 138. The analog front-end 150 may include a transimpedance amplifier, a filter, an ambient light suppression module, and an analog-to-digital converter (ADC). The transimpedance amplifier can be used to convert the photocurrent signal into a voltage signal; the filter can be used to filter out noise signals; the ambient light suppression module can be used to reduce the influence of external ambient light on the detection results; and the analog-to-digital converter can be used to convert the analog signal into a digital signal.
[0174] In some examples, control circuitry 160 can be connected to processor 170, analog front-end 150, and optical sensing module 130. Control circuitry 160 can be used to control the driving process of green LED 134 and infrared LED 136, and to achieve timing synchronization. For example, control circuitry 160 can control different LEDs to emit light in turn according to a preset timing sequence, so as to distinguish detection signals corresponding to different wavelengths.
[0175] In some examples, processor 170 may include an MCU and / or a DSP. Processor 170 may be used to perform data processing, control, and algorithmic operations. Processor 170 may receive digital signals from analog front-end 150 and input the digital signals to glucose estimation algorithm 180.
[0176] In some examples, glucose estimation algorithm 180 can be used to estimate a user's glucose level based on optical detection signals. Glucose estimation algorithm 180 may include processes such as PPG signal processing, feature extraction, calibration / modeling, and glucose estimation. Specifically, PPG signal processing may include operations such as filtering and normalization; feature extraction may be used to extract time-domain features, frequency-domain features, or pulse waveform features related to blood glucose changes; calibration / modeling may be used to establish the correspondence between optical features and glucose concentration; and glucose estimation may be used to output the corresponding glucose estimation result.
[0177] In some examples, the display / output module 112 may be connected to the processor 170. The display / output module 112 may be used to output glucose estimation results. For example, the display / output module 112 may display glucose values (e.g., 112 mg / dL) through a display interface, and may also provide prompts to the user through sound, vibration, or haptic feedback.
[0178] In some examples, the wireless communication module 200 can be connected to the processor 170. The wireless communication module 200 can support wireless communication protocols such as BLE, ANT+, and / or Wi-Fi. The wireless communication module 200 can be used for data communication with external devices, such as exchanging detection data, analysis results, or control information with mobile terminals, servers, or other smart devices.
[0179] In some examples, power module 190 can be used to provide power to optical sensing module 130, analog front-end 150, control circuitry 160, processor 170, and wireless communication module 200. Power module 190 may include a battery and power management circuitry. The power management circuitry can be used to implement power supply control, voltage conversion, and power consumption management.
[0180] In some examples, processor 170 can coordinate and control the data interaction between optical sensing module 130, analog front end 150, control circuit 160, glucose estimation algorithm 180, display / output module 112 and wireless communication module 200, thereby realizing glucose estimation, result output and wireless data transmission based on optical detection signals.
[0181] In some examples, the second analyte device 2 may include a sensor at least partially implanted under the skin of the target subject. The sensor may be configured to generate an electrical signal based on the target analyte (i.e., the test analyte) in the tissue fluid. In some examples, the sensor of the second analyte device 2 may be an electrochemical sensor. The electrochemical sensor may contact the analyte in the tissue fluid under the target subject's skin and generate an electrical signal related to the analyte level.
[0182] Figure 11 is a schematic diagram illustrating the body unit 21 involved in the example of this disclosure.
[0183] In some examples, the second analyte device 2 may include a continuous analyte monitoring device. In some examples, when the analyte is glucose, the continuous analyte monitoring device may be a continuous glucose monitoring device. In some examples, referring to FIG11, the second analyte device 2 may include an on-body unit 21. In some examples, the on-body unit 21 may include a sensor (not shown in the figure) at least partially implanted under the skin of the target subject. In some examples, the implanted portion of the sensor may be elongated and positioned in the dermis or subcutaneous tissue space to contact the tissue fluid and collect analyte information in the tissue fluid.
[0184] In some examples, the sensor may include a working electrode and a counter electrode, with a sensing layer comprising an analyte enzyme (e.g., glucose oxidase) disposed on the working electrode. Placed subcutaneously, the sensor can utilize the analyte enzyme to undergo a redox reaction with the analyte in tissue fluid or blood, forming a circuit with the counter electrode to generate a current signal related to the analyte concentration. In some examples, the sensor may also include a reference electrode, which can form a known and relatively stable potential difference with the tissue fluid or blood, allowing electronics to adjust and maintain a stable voltage at the working electrode according to a preset voltage value.
[0185] In some examples, referring to FIG11, the body unit 21 may include an applicator 211 configured to adhere the body unit 21 to the body surface of a target object. In some examples, the applicator 211 may include an adhesive patch and be fixed to the body surface of the target object by the adhesive patch. The electronic device 212 (described later) may receive electrical signals generated by the sensor, amplify, filter, temperature compensate, calibrate, and digitize the electrical signals, and transmit the processed continuous analyte data wired or wirelessly to a reading device, a mobile terminal, the first analyte device 1, or a server. Thus, the second analyte device 2 can provide continuous reference data to the medical device system within a first time period for determining the individualized calibration relationship of the first analyte device 1.
[0186] In some examples, body unit 21 may include electronics 212 or a transmitter operatively connected to the sensor. In some examples, electronics 212 may be configured to process signals (e.g., electrical signals) from the sensor and output continuous second analyte data. In some examples, continuous second analyte data may be output via wired or wireless means.
[0187] Figure 12 is an application overview diagram of the continuous analyte monitoring system according to the example of this disclosure. Figure 13 is a schematic diagram showing the assembly of the pretreatment unit 21 and the application device 8 according to the example of this disclosure.
[0188] In some examples, referring to FIG12, the second analyte device 2 may be a body unit 21 in a continuous analyte monitoring system. In some examples, the continuous analyte monitoring system may include a body unit 21 and an application device 8, the body unit 21 being applied to a host via the application device 8, the host obtaining analyte information through the body unit 21 applied to itself. In some examples, the body unit 21 may be applied to a desired location. In this disclosure, the body unit 21 may also be referred to as body unit 21. In some examples, referring to FIG12, the application device 8 may include a receiving portion 81 and a bottom cover 82. The receiving portion 81 may be configured to receive the body unit 21. The bottom cover 82 may be configured to couple with the receiving portion 81 to encapsulate the receiving portion 81.
[0189] In some examples, referring to FIG13, the body unit 21 may be disposed within the application device 8 before use. For example, the body unit 21 may be clamped within the application device 8.
[0190] In some examples, the continuous analyte monitoring system may include a reading device (not shown) that is communicatively connected to the body unit 21. The body unit 21, applied to the host (e.g., the target object), can transmit the acquired analyte information to the reading device, for example, wirelessly, thereby enabling the host to read and monitor its own analyte information.
[0191] In some examples, the on-body unit 21 can be configured to acquire the analyte level in the host. In some examples, the on-body unit 21 can be a sensing device. In some examples, the on-body unit 21 can be an analyte sensor device that can generate information about a specific analyte in the body fluid based on the body fluid, such as reacting with the analyte in the body fluid and generating analyte information. In this case, by reacting with the analyte in the body fluid through the sensor, it is possible to easily acquire information about the analyte in the body fluid. For example, the on-body unit 21 can be applied to the surface of the host and at least partially located under the host's skin to acquire the analyte concentration under the host's skin.
[0192] In some examples, the body unit 21 may include a sensor and an applicator 211. In some examples, the sensor may be supported on the applicator 211. In this disclosure, the applicator 211 may also be referred to as a transmitter.
[0193] In some examples, the sensor can be placed partially or entirely under the host's skin. In other words, the sensor can be placed at least partially under the skin. This allows for the monitoring of analyte information in the subcutaneous tissue fluid.
[0194] In some examples, the sensor, once placed subcutaneously, can react with analytes in the subcutaneous tissue fluid to generate analyte information for the host. The patch 211 can be applied to the host's body surface. In some examples, the patch 211 can also receive the analyte information generated by the sensor. In some examples, the patch 211 can also provide the sensor with the electrical energy required to acquire analyte information. This facilitates continuous monitoring by the sensor under the host's skin.
[0195] In some examples, the implanted portion of the sensor can be elongated. In others, it can be rigid, which facilitates placement under the host's skin. In still others, the implant can be flexible, reducing the host's sensation of a foreign body. In some examples, after implantation, the portion reaches the dermis and is located within the interstitial tissue of the skin, allowing the sensor to collect analyte information from the interstitial fluid.
[0196] In some examples, the patch 211 may also include a hole 2111 extending from the upper surface to the lower surface (see FIG. 11), and when the sensor is mounted on the patch 211, the axis of the sensor can pass through the hole (see FIG. 11). In this case, a sharp object used to guide the sensor can be inserted subcutaneously through the hole, thereby facilitating the placement of the sensor subcutaneously.
[0197] In some examples, the implantation portion may include a working electrode and a counter electrode. In this disclosure, a sensing layer including an analyte enzyme may be disposed on the working electrode. The sensor, placed subcutaneously, can generate a current signal by reacting with the analyte enzyme on the working electrode in a redox reaction with the analyte in tissue fluid or blood, forming a circuit with the counter electrode. This current signal is then analyzed to obtain analyte concentration information. In some examples, the current signal generated by the sensor can be transmitted to the dressing portion 211.
[0198] In some examples, the implanted portion may also include a reference electrode. In some examples, the reference electrode may form a known and fixed potential difference with the tissue fluid or blood. In this case, the potential difference between the working electrode and the tissue fluid or blood can be measured by the potential difference formed between the reference electrode and the working electrode. This allows for a more accurate determination of the voltage generated by the working electrode. Consequently, the electronic device 212 of the dressing portion 211 can automatically adjust and maintain a stable voltage at the working electrode according to a preset voltage value, so that the measured current signal can more accurately reflect the analyte concentration information in the tissue fluid or blood. In some examples, the number of reference electrodes may be one or more, for example, two.
[0199] In some examples, the patch 211 is configured to adhere to the surface of a host. In some examples, the patch 211 may also include an adhesive sheet 2112 with adhesive properties (see FIG. 11). The patch 211 can be applied to and fixed to the surface of the host's body by the adhesive sheet 2112.
[0200] In some examples, the projection of the body unit 21 along the central axis of the application device 8 has a runway-shaped profile.
[0201] Figure 14 is a block diagram illustrating the electronic device 212 of the body unit 21 according to the present disclosure example.
[0202] In some examples, the application unit 211 may also include an electronic device 212 (see FIG. 14). The electronic device 212 may receive analyte information generated by the sensor. In some examples, the electronic device 212 may further process the analyte information. In other examples, the electronic device 212 may also transmit the received analyte information to an external device, such as a reading device described below. Additionally, the electronic device 212 may also power the sensor.
[0203] In some examples, electronic device 212 may include a power module 2121, a switch module 2122, and a processing module 2123. The power module 2121 can supply power to the sensor and / or processing module 2123, the switch module 2122 can control the on / off state between the power module 2121 and the sensor and / or processing module 2123, and the processing module 2123 can process the signals generated by the sensor (e.g., analyte information). In some examples, electronic device 212 may also include a storage module 2124 (see FIG. 14). The storage module 2124 can store the signals generated by the sensor. Additionally, in some examples, electronic device 212 may also include a communication module 2125 (see FIG. 14). The communication module 2125 can communicate with external devices (e.g., smart terminal devices). In some examples, the communication module 2125 may be a Bluetooth module, an NFC module, a Wi-Fi module, etc. In some examples, the smart terminal device may be a smartphone, a smartwatch, a tablet computer, a computer, etc.
[0204] As described above, in some examples, the medical device system may include a processing device 3. The acquisition step may be performed by the processing device. Furthermore, the processing device 3 may not be the first analyte device 1 or the second analyte device 2. For example, the processing device 3 may include at least one of a mobile terminal (e.g., a smartphone) and a server (e.g., a cloud server). This reduces the burden on the analyte devices to process data.
[0205] This disclosure also discloses an electronic device including a processor and a memory. The processor executes a program stored in the memory to perform one or more steps in the acquisition method described above.
[0206] Examples of this disclosure also disclose a computer-readable storage medium that can store at least one instruction, which, when executed by a processor, implements one or more steps in the acquisition method. The computer-readable storage medium can be, but is not limited to, any type of disk, including floppy disks, optical disks, DVDs, CD-ROMs, microdrives, and magneto-optical disks, ROMs, RAMs, EPROMs, EEPROMs, DRAMs, VRAMs, flash memory devices, magnetic cards or optical cards, nanosystems (including molecular memory ICs), or any type of medium or device suitable for storing instructions and / or data.
[0207] While the present disclosure has been specifically described above in conjunction with the accompanying drawings and examples, it is to be understood that the foregoing description does not limit the present disclosure in any way. Those skilled in the art can make modifications and variations to the present disclosure as needed without departing from its scope, and all such modifications and variations shall fall within the scope of the present disclosure.
[0208] Exemplary implementations are given by the elements numbered below, which can be combined in any mutually consistent manner.
[0209] Element 1. A medical device system, comprising a first analyte device and a second analyte device; the first analyte device is configured to acquire continuous first measurement data of a target object over a first time period; the second analyte device is configured to acquire continuous second analyte data of the target object over the first time period; the first analyte device is further configured to acquire continuous third measurement data of the target object over a second time period after the first time period, wherein the first measurement data, the second analyte data, and the third measurement data are the same analyte data; and to acquire analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data.
[0210] Element 2. The medical device system according to Element 1, wherein the first analytical device and the second analytical device are two analytical devices implemented in different ways.
[0211] Element 3. The medical device system according to Element 2, wherein the implementation method includes at least one of the following: monitoring principle, monitoring frequency, manufacturer, and equipment version.
[0212] Element 4. The medical device system according to any one of Elements 1 to 3, wherein the relationship between the first analyte device and the second analyte device satisfies at least one of the following: the monitoring frequency of the second analyte device is greater than the monitoring frequency of the first analyte device; the service life of the first analyte device is greater than the service life of the second analyte device; the usage cost of the first analyte device is less than the usage cost of the second analyte device; the second analyte device is an invasive analyte monitoring device, and the first analyte device is a non-invasive analyte monitoring device.
[0213] Element 5. The medical device system according to Element 4, wherein the non-invasive analyte monitoring device is located on the skin of the target object, and at least a portion of the invasive analyte monitoring device is located subcutaneously in the target object.
[0214] Element 6. The medical device system according to Element 4 or 5, wherein the non-invasive analyte monitoring device is a device that uses optical, microwave, radio frequency or ultrasound technology to monitor analyte levels.
[0215] Element 7. The medical device system according to any one of Elements 1 to 6, wherein the first measurement data and the second analyte data are time-corresponding analyte data acquired simultaneously by the first analyte device and the second analyte device within the first time period.
[0216] Element 8. The medical device system according to any one of Elements 1 to 6, wherein the first measurement data and the second analyte data are associated analyte data, and the monitoring time of the first measurement data and the monitoring time of the second analyte data are based on event correspondence.
[0217] Element 9. The medical device system according to Element 8, wherein the event includes eating time.
[0218] Element 10. The medical device system according to any one of Elements 1 to 9, wherein the first time period includes at least a portion of a plurality of time periods.
[0219] Element 11. The medical device system according to Element 10, wherein the time period is one day.
[0220] Element 12. The medical device system according to any one of Elements 1 to 11, wherein the second analyte device is an invasive analyte monitoring device, and the first time period is the time period after the target object has used the second analyte device for a predetermined time period.
[0221] Element 13. The medical device system according to element 12, wherein the predetermined time period is thirty minutes or one hour.
[0222] Element 14. The medical device system according to any one of elements 1 to 13, wherein the third measurement data is analyte data measured when the target object wears only the first analyte device.
[0223] Element 15. The medical device system according to any one of elements 1 to 14, wherein the same analyte data is glucose data.
[0224] Element 16. The medical device system according to any one of Elements 1 to 14, wherein the same analyte data is any one of blood ketones, acetylcholine, amylase, bilirubin, cholesterol, creatine kinase, creatine, creatine anhydride, DNA, fructosamine, glutamine, hormones, ketone bodies, lactate, peroxides, prostate-specific antigen, prothrombin, RNA, and troponin.
[0225] Element 17. The medical device system according to any one of Elements 1 to 16, wherein the continuous analyte data is analyte data collected by the analyte device at predetermined time intervals, and the analyte data includes at least one analyte level.
[0226] Element 18. The medical device system according to any one of Elements 1 to 17, wherein the analyte level information includes at least one of the analyte data itself and evaluation data of the analyte data.
[0227] Element 19. The medical device system according to Element 18, wherein the analyte level information includes at least one of the calibrated third measurement data, analyte fluctuation information, analyte control information, and analyte statistics.
[0228] Element 20. The medical device system according to Element 19, wherein the analyte statistics include the average analyte level.
[0229] Element 21. The medical device system according to any one of Elements 1 to 20, wherein the relationship between the first measurement data and the second analyte data includes at least one of correlation, environmental dependence, and calibration.
[0230] Element 22. The medical device system according to element 21, wherein the correlation relationship includes a linear relationship or a nonlinear relationship.
[0231] Element 23. The medical device system according to any one of elements 1 to 22, wherein the monitoring frequency of the second analyte device is greater than the monitoring frequency of the first analyte device, the relationship being represented by interpolated data between the analyte levels at two time points of the first measurement data determined by the second analyte data.
[0232] Element 24. A medical device system according to any one of Elements 1 to 23, wherein the accuracy of the second analyte device is greater than the accuracy of the first analyte device, the relationship is a mapping relationship between target information of the first measurement data and target information of the second analyte data, the analyte level information includes information related to the target information of the mapped third measurement data; obtaining the analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data includes establishing the mapping relationship and determining the target information of the third measurement data mapped via the mapping relationship based on the mapping relationship.
[0233] Element 25. The medical device system according to Element 24, wherein the target information includes at least one of single-point analyte level, multi-point continuous analyte level, and analyte fluctuation information.
[0234] Element 26. The medical device system according to element 24 or 25, wherein the mapping relationship is determined by statistical analysis, curve fitting or machine learning methods.
[0235] Element 27. The medical device system according to any one of Elements 24 to 26, wherein the mapping relationship includes at least one of key-value pair mapping, functional mapping, and machine learning model-based mapping.
[0236] Element 28. The medical device system according to any one of Elements 24 to 27, wherein the mapping relationship is established based on target information of the first measurement data and target features within the first time period, the target features being features that are repeatable within the second time period and related to changes in analyte levels.
[0237] Element 29. The medical device system according to Element 28, wherein, for the key-value pair mapping, the target information and the target feature are used as keys, and the mapped target information is used as a value; for the functional mapping, the target information and the target feature are used as inputs to a function, and the mapped target information is used as the output of a function; for the machine learning model-based mapping, the target information and the target feature are used as inputs to a machine learning model, and the mapped target information is used as the output of the machine learning model.
[0238] Element 30. The medical device system according to element 28 or 29, wherein the target feature includes at least one of an event, a data feature of the first measurement data, and an environmental feature.
[0239] Element 31. The medical device system according to any one of Elements 28 to 30, wherein the target feature is user-customizable.
[0240] Element 32. The medical device system according to any one of elements 28 to 30, wherein the target feature is not user-customizable.
[0241] Element 33. The medical device system according to any one of elements 28 to 30, wherein the target feature includes a first target feature that can be customized by the user and a second target feature that cannot be customized by the user.
[0242] Element 34. The medical device system according to any one of elements 30 to 33, wherein the event is associated with the behavior and / or physical condition of the target object.
[0243] Element 35. The medical device system according to element 34, wherein the event includes at least one of diet, exercise, medication, sleep, and physical condition.
[0244] Element 36. The medical device system according to element 35, wherein the physical condition includes at least one of physiological and psychological factors that cause changes in analyte levels.
[0245] Element 37. The medical device system according to any one of elements 30 to 36, wherein the data feature is a pattern of analyte level changes identified from the first measurement data.
[0246] Element 38. The medical device system according to element 37, wherein the type of the data features is known prior to determining the relationship.
[0247] Element 39. The medical device system according to Element 37, wherein the types of data features are dynamic, and the types of data features of the analyte data of the target object are determined by clustering the data features in the first measurement data.
[0248] Element 40. The medical device system according to any one of elements 30 to 39, wherein the environmental characteristics are related to the environment at the location where the first analyte device is located.
[0249] Element 41. The medical device system according to any one of elements 30 to 40, wherein the environmental characteristics include at least one of contact status, temperature information, and humidity information.
[0250] Element 42. The medical device system according to element 41, wherein the contact state indicates whether the first analyte device is in close contact with the target object, expressed as a pressure value on the surface of the target object or an impedance between the first analyte device and the target object.
[0251] Element 43. A medical device system according to any one of Elements 1 to 23, wherein the accuracy of the second analyte device is greater than the accuracy of the first analyte device, the relationship is represented using at least one calibration coefficient, and the analyte level information includes information related to the calibrated third measurement data; obtaining the analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data includes calibrating the first measurement data based on the second analyte data to obtain the at least one calibration coefficient, and calibrating the third measurement data based on the at least one calibration coefficient to obtain the calibrated third measurement data.
[0252] Element 44. The medical device system according to element 43, wherein a calibration coefficient is determined by calibrating the first measurement data to adjust the first measurement data so that the first measurement data is close to or consistent with a standard value, the standard value being the analyte level in the second analyte data or a known value determined by the second analyte data.
[0253] Element 45. The medical device system according to element 44, wherein the known values include the baseline values of the target object determined by the second analyte data.
[0254] Element 46. The medical device system according to any one of elements 43 to 45, wherein the calibration coefficient is the difference or ratio between the second analyte data and the first measurement data.
[0255] Element 47. The medical device system according to any one of elements 43 to 46, wherein the calibration coefficient is stored in the memory of the first analyte device or the memory of the processing device.
[0256] Element 48. A medical device system according to any one of elements 43 to 47, wherein, when calibrating the first measurement data, in response to identifying a target feature within the first time period, the target feature is associated with a corresponding calibration coefficient; and when calibrating the third measurement data, in response to identifying the target feature, the third measurement data is calibrated based on the associated calibration coefficient; the target feature is a feature that is repeatable within the second time period and is related to changes in analyte levels.
[0257] Element 49. The medical device system according to element 48, wherein the medical device system is configured to create a data list for storing calibration information, the calibration information including the calibration coefficients and the target features associated with the calibration coefficients.
[0258] Element 50. The medical device system according to element 49, wherein the calibration information further includes the placement location of the first analyte device on the target object associated with the calibration coefficient.
[0259] Element 51. The medical device system according to any one of Elements 48 to 50, wherein, when calibrating the third measurement data, the calibration coefficient is obtained from the correlation between the calibration coefficient and the target feature based on the target feature identified in the third measurement data.
[0260] Element 52. The medical device system according to Element 51, wherein if no associated calibration coefficient is found based on the identification result, at least one feature combination of the target features in the identification result is determined, and an associated calibration coefficient is determined based on the feature combination.
[0261] Element 53. The medical device system according to element 52, wherein the number of target features in each feature combination is less than the number of target features in the identification result.
[0262] Element 54. The medical device system according to element 52 or 53, wherein, each time at least one combination of features is determined, the number of target features in the combination of features decreases by 1.
[0263] Element 55. The medical device system according to any one of Elements 51 to 54, wherein if no associated calibration coefficient is found from at least one calibration coefficient based on the identification result, the associated calibration coefficient is determined based on the priority of the target feature in the identification result.
[0264] Element 56. The medical device system according to Element 55, wherein the priority of different target features is determined by analyzing historical data.
[0265] Element 57. The medical device system according to any one of Elements 48 to 56, wherein, when calibrating the first measurement data, the at least one calibration coefficient is associated with the placement position of the first analyte device on the target object; and when calibrating the third measurement data, the at least one associated calibration coefficient is determined based on the placement position of the first analyte device on the target object, and the third measurement data is calibrated using the at least one associated calibration coefficient.
[0266] Element 58. The medical device system according to element 57, wherein the placement position of the first analytical device on the target object is input by the target object.
[0267] Element 59. The medical device system according to any one of elements 1 to 58, wherein the first measurement data and the second analyte data are timestamped before the relationship is determined.
[0268] Element 60. The medical device system according to any one of elements 1 to 59 further includes a processing device, which is not the first analyte device or the second analyte device and is configured to obtain analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data.
[0269] Element 61. The medical device system according to element 60, wherein the processing device includes at least one of a mobile terminal and a server.
[0270] Element 62. The medical device system according to element 61, wherein the mobile terminal is a smartphone and the server is a cloud server.
[0271] Element 63. A medical device system according to any one of Elements 1 to 59, wherein the first analyte device includes a first light source configured to emit a first measuring light, a first sensor located on the skin of a target object, and a first processing module; the first sensor receives a first reflected light corresponding to the first measuring light; the first processing module is configured to obtain analyte data based on the first measuring light and the first reflected light; the first measuring data is analyte data for a first time period obtained by the first processing module, and the third measuring data is analyte data for a second time period obtained by the first processing module; the first processing module is further configured to receive the second analyte data and obtain analyte level information corresponding to the third measuring data based on the relationship between the first measuring data and the second analyte data.
[0272] Element 64. The medical device system according to Element 63, wherein the first light source emits the first measuring light toward the surface of the target object, the first measuring light being light in the near-infrared or mid-infrared spectral range.
[0273] Element 65. The medical device system according to element 63 or 64, wherein the first processing module is configured to obtain the spectrum of the first reflected light, obtain the light intensity corresponding to the absorption peak of the analyte based on the spectrum of the first reflected light, and calculate the analyte data according to the mathematical relationship between the light intensity and the analyte data.
[0274] Element 66. The medical device system according to element 65, wherein the first processing module is configured to obtain analyte data by multiplying the light intensity by a conversion factor of the first analyte device.
[0275] Element 67. The medical device system according to element 66, wherein the conversion coefficient is the sensitivity of the first analyte device.
[0276] Element 68. The medical device system according to any one of elements 63 to 67, wherein the first analyte device further includes a detection module configured to acquire environmental characteristics of the environment in which the first analyte device is located.
[0277] Element 69. The medical device system according to element 68, wherein the detection module includes a contact detection module configured to detect the contact state between the first analyte device and the target object.
[0278] Element 70. The medical device system according to element 69, wherein the contact detection module includes at least one of a pressure sensor, a contact electrode, and an ultrasound module.
[0279] Element 71. The medical device system according to Element 70, wherein the pressure sensor is configured to detect pressure between the first analyte device and the target object; the contact electrode is configured to detect impedance between the first analyte device and the target object; and the ultrasound module is configured to detect contact parameters between the first analyte device and the target object, the contact parameters including contact area or tissue thickness.
[0280] Element 72. The medical device system according to any one of elements 68 to 71, wherein the detection module includes a temperature sensor configured to acquire temperature information.
[0281] Element 73. The medical device system according to any one of elements 68 to 72, wherein the detection module includes a humidity sensor configured to acquire humidity information.
[0282] Element 74. The medical device system according to any one of elements 68 to 73, wherein the detection module includes an accelerometer configured to acquire motion signals.
[0283] Element 75. The medical device system according to element 74, wherein the acceleration sensor is further configured to identify events based on the motion signal.
[0284] Element 76. The medical device system according to any one of elements 1 to 75, wherein the second analytical device includes a sensor at least partially implanted under the skin of the target object.
[0285] Element 77. The medical device system according to Element 76, wherein the sensor of the second analyte device is an electrochemical sensor configured to contact the analyte in the tissue fluid under the skin of the target object and generate an electrical signal related to the analyte level.
[0286] Element 78. A method for acquiring analyte level information using a first analyte device, comprising: acquiring continuous first measurement data of a target object over a first time period acquired by the first analyte device; acquiring continuous second analyte data of the target object over the first time period acquired by a second analyte device; acquiring continuous third measurement data of the target object over a second time period acquired by the first analyte device after the first time period, wherein the first measurement data, the second analyte data, and the third measurement data are of the same analyte; and acquiring analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data.
[0287] Element 79. The method according to element 78, wherein the accuracy of the second analyte device is greater than the accuracy of the first analyte device, the relationship is a mapping relationship between the target information of the first measurement data and the target information of the second analyte data, and the analyte level information includes information related to the target information of the mapped third measurement data; obtaining the analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data includes establishing the mapping relationship and determining the target information of the third measurement data mapped via the mapping relationship based on the mapping relationship.
[0288] Element 80. The method according to element 79, wherein the target information includes at least one of single-point analyte level, multi-point continuous analyte level, and analyte fluctuation information.
[0289] Element 81. The method according to element 79 or 80, wherein the mapping relationship is established based on target information of the first measurement data and target features within the first time period, the target features being features that are repeatable within the second time period and related to changes in the level of the analyte.
[0290] Element 82. The method according to element 78, wherein the accuracy of the second analyte device is greater than the accuracy of the first analyte device, the relationship is represented by at least one calibration coefficient, and the analyte level information includes information related to the calibrated third measurement data; obtaining the analyte level information corresponding to the third measurement data based on the relationship between the first measurement data and the second analyte data includes calibrating the first measurement data based on the second analyte data to obtain the at least one calibration coefficient, and calibrating the third measurement data based on the at least one calibration coefficient.
[0291] Element 83. The method according to element 82, wherein, when calibrating the first measurement data, in response to identifying a target feature within the first time period, the target feature is associated with a corresponding calibration coefficient; and when calibrating the third measurement data, in response to identifying the target feature, the third measurement data is calibrated based on the associated calibration coefficient, wherein the target feature is a feature that is repeatable within the second time period and is related to changes in analyte levels.
[0292] Element 84. The method according to element 83, wherein the target feature includes at least one of the event, data features of the first measurement data, and environmental features.
[0293] Element 85. The method according to any one of elements 82 to 84, wherein, when calibrating the first measurement data, the at least one calibration coefficient is associated with the placement position of the first analyte device on the target object; and when calibrating the third measurement data, the associated at least one calibration coefficient is determined based on the placement position of the first analyte device on the target object, and the third measurement data is calibrated using the associated at least one calibration coefficient.
[0294] Element 86. The method according to any one of Elements 78 to 85, wherein the relationship between the first analyte device and the second analyte device satisfies at least one of the following: the monitoring frequency of the second analyte device is greater than the monitoring frequency of the first analyte device; the service life of the first analyte device is greater than the service life of the second analyte device; the usage cost of the first analyte device is less than the usage cost of the second analyte device; the second analyte device is an invasive analyte monitoring device, and the first analyte device is a non-invasive analyte monitoring device.
[0295] Element 87. The method according to any one of elements 78 to 86, wherein the first measurement data and the second analyte data are timestamped before the relationship is determined.
[0296] Element 88. An electronic device comprising a processor and a memory, the processor executing a program stored in the memory to perform one or more steps of the method as described in any one of elements 78 to 87.
[0297] Element 89. A computer-readable storage medium storing at least one instruction that, when executed by a processor, implements one or more steps of the method as described in any one of Elements 78 to 87.
[0298] Element 90. The computer-readable storage medium according to element 89, wherein the computer-readable storage medium includes any one of disk, ROM, RAM, EPROM, EEPROM, DRAM, VRAM, flash memory device, magnetic card or optical card, and nanosystem.
Claims
1. A medical instrument system, characterized by The medical instrument system comprises a first analyte device, a second analyte device, and a processing device; the first analyte device is configured to acquire continuous first measurement data of a target object in a first time period in a non-invasive or low-invasive manner, and to acquire continuous third measurement data of the target object in a second time period after the first time period, the first measurement data and the third measurement data comprising at least one of original detection signals, feature data derived from the original detection signals, and initial analyte data; the second analyte device is a continuous analyte monitoring device and is configured to acquire continuous second analyte data of the target object in the first time period; the processing device is configured to determine a calibration relationship based on a correspondence between the first measurement data and the second analyte data at multiple time points in the first time period, and to process the third measurement data based on the calibration relationship to obtain calibrated analyte level information.
2. The medical instrument system of claim 1, wherein, The processing device is configured to establish a mapping model by taking target information in the first measurement data and target information in the second analyte data as training samples or fitting samples, and to determine at least one of a target analyte level, an analyte change trend, a low analyte state, a high analyte state, and analyte fluctuation information corresponding to the third measurement data based on the mapping model.
3. The medical instrument system of claim 1, wherein, The processing device is further configured to perform at least one of timestamp alignment, sampling frequency matching, filtering, outlier rejection, time delay estimation, and trend segment matching on the first measurement data and the second analyte data before determining the calibration relationship, so that the continuous data from the second analyte device serves as individualized continuous reference data of the first analyte device.
4. The medical instrument system of any one of claims 1 to 3, wherein, The first analyte device comprises an optical analyte device, and the original detection signals comprise at least one of photoplethysmography signals, reflection spectrum signals, transmission spectrum signals, diffuse reflection spectrum signals, light intensity signals, absorption spectrum signals, and scattering signals.
5. The medical instrument system of any one of claims 1 to 3, wherein, The feature data comprises at least one of light intensity ratios at different wavelengths or different channels, alternating current components, direct current components, pulse waveform features, absorption peak features, spectrum segment filtering features, temperature compensation features, and contact state features.
6. The medical instrument system of any one of claims 1 to 3, wherein, The processing device is configured to determine a plurality of sub-calibration relationships according to target features in the first time period, and to invoke a corresponding sub-calibration relationship to process the third measurement data in response to identifying a feature identical to or matching the target feature in the second time period.
7. The medical instrument system of any one of claims 1 to 3, wherein, The target features comprise at least one of diet, exercise, medication, sleep, physical condition, data waveform morphology, change rate, temperature, humidity, contact state, and wearing position.
8. The medical instrument system of any one of claims 1 to 3, wherein, The processing device is configured to constrain the calibration relationship based on trend information of the second analyte data, the trend information comprising at least one of an upward trend, a downward trend, a stable trend, a change rate, a change acceleration, a postprandial peak, a nighttime low, and a time within a target range.
9. The medical instrument system of any one of claims 1 to 3, wherein, The processing device is further configured to update or suspend updating the calibration relationship based on a quality indicator of the first measurement data and / or the second analyte data.
10. The medical instrument system of claim 1, wherein, The second analyte device comprises an on-body unit comprising an electrochemical sensor at least partially positioned subcutaneously in the target subject and in contact with interstitial fluid, and an electronic device operatively connected to the electrochemical sensor; the electrochemical sensor is configured to generate an electrical signal based on a target analyte in the interstitial fluid, and the electronic device is configured to process the electrical signal and output the continuous second analyte data via wired or wireless means.
11. The medical instrument system of claim 10, wherein, Further comprising an application part configured to adhere the on-body unit to the body surface of the target subject.
12. The medical instrument system of claim 1, wherein, The second analyte device comprises a continuous glucose monitoring device, and the analyte is glucose; the first analyte device is a non-invasive glucose monitoring device, and is configured to obtain glucose level information in the second time period using the calibration relationship determined from the continuous glucose data of the continuous glucose monitoring device when the second analyte device is removed, disabled, or not worn.
13. The medical instrument system of claim 1, wherein, The processing device is disposed in at least one of the first analyte device, the second analyte device, a mobile terminal, a reading device, and a server; when the processing device is disposed in a mobile terminal, a reading device, or a server, the processing device is configured to receive the first measurement data and / or the third measurement data from the first analyte device, and receive the second analyte data from the second analyte device.
14. The medical instrument system of claim 1, wherein, The first analyte device comprises a first light source configured to emit a first measurement light, a first sensor positioned on the body surface of the target subject, and a first processing module; the first sensor receives first reflected light, first transmitted light, or first scattered light corresponding to the first measurement light; the first processing module is configured to obtain the first measurement data and the third measurement data based on the first measurement light and the received light, and output at least one of calibrated analyte level, analyte change trend, analyte abnormality alert, and analyte control evaluation based on the calibration relationship.
15. The medical instrument system of claim 1, wherein, The processing device is configured to extract a plurality of continuous feature vectors from the first measurement data using a sliding time window in the first time period, and pair the plurality of continuous feature vectors with continuous analyte values, analyte change rates, or analyte trend labels in a corresponding time window in the second analyte data to train or update an individualized calibration model.
16. The medical instrument system of claim 1, wherein, The calibration relationship comprises a mapping model, a calibration coefficient, an offset, a proportionality coefficient, a time delay parameter, a feature weight, or a combination thereof.
17. The medical instrument system of claim 1, wherein, The calibration relationship comprises a global calibration relationship for processing basic state data in the second time period, and a local calibration relationship for processing data corresponding to postprandial, exercise, sleep, sweating, poor contact, or change in wearing position.
18. A method for obtaining analytical level information, characterized in that, comprising: obtaining, by a first analyte device, continuous first measurement data of a target subject in a first time period; obtaining, by a second analyte device, continuous second analyte data of the target object in the first time period, wherein the second analyte device is a continuous analyte monitoring device; determining a calibration relationship based on a time sequence correspondence between the first measurement data and the second analyte data at multiple time points; obtaining, by the first analyte device, continuous third measurement data in a second time period after the first time period; and processing the third measurement data based on the calibration relationship to obtain calibrated analyte level information.
19. The acquisition method of claim 18, wherein, Determining the calibration relationship includes at least one of the following: training a regression model based on a photoplethysmogram signal and the second analyte data; updating coefficients of a partial least squares model based on near-infrared spectroscopy signals and the second analyte data; segmenting the second analyte data based on events, environmental features, or contact states and respectively determining sub-calibration relationships.
20. An electronic device or a computer-readable storage medium, comprising: The electronic device includes a processor and a memory, or the computer readable storage medium stores a program; the program is executed by the processor to implement the obtaining method of claim 18 or 19.
